ClinicalTrials.govpublic full text
Bortezomib and High-dose Melphalan at Myeloma Relapse
multiple myeloma, high-dose melphalan, bortezomib, response, toxicity, relapse, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851622
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.